Member Info for nomlungu

http://www.mineralandfinancial.com/wp-content/uploads/2016/11/Drill-results-16-Oct-2017.pdf The Lagoa Salgada resource is centred on one gravimetric anomaly called LS-1. There are a total of 17 gravimetric anomalies on the property. These anomalies remain to be fully tested. A petrographic study undertaken by TH Crestgate focused on the LS-1 area of the Lagoa Salgada property and also indicated the presence of anomalously high levels of indium in sphalaritic zones of mineralization. Mineralisation is composed of a central stock work zone - a more than 700m thick volcano-sedimentary complex - and a massive sulphide lens in the northwest. It is covered by more than one hundred meters of sediments of the Sado Tertiary basin Later it states: This report should be seen as indicative of possible mineral content and not definitive, as the sample group is insufficient to arrive at any economic conclusions. Any potential investor should start by researching the RNS - spikes in the share price will happen but significant cash flow seems to me to be years away.

too true

time will tell - I think it is herd mentality not with my money though

please buy - I want o read your moaning comments over the next weeks

yup... but I do not like the feeling of being mugged.

fred... what do we know?

mice do not bounce as much

Moan Moan Moan Moan: I have emailed their investor contact as follows: I have a small investment here and am really concerned about how the handling of the change of CEO appears to have influenced the share price. Whilst I note the changes to the website reflecting CellRight�s growing importance, I hope that future announcements include greater clarity when possible.

or maybe not?

An oldish article about hRPCs worth reading: http://www.blindness.org/ReNeuron I suppose we should consider ourselves lucky as this is a bit of a dollar hedge in the event that a messy brexit results in UK medical sector loosing EU accreditation.

I thought that the small price rise would be sustained - how wrong. I may [or maybe not?] be deluded but I do have long term faith in ReNeuron's approach but believe that the future prize of possible dividends is still many years away. But then again ReNeuron is all about future possibilities so this remains firmly in my 'bottom drawer' collection of moonshot shares.

This has dropped a lot - my logarithm said I had to buy more. Not happy though.

well spotted.

Where are we in the mining investment cycle? The words of MAFL's Chief Investment Officer and Executive Director: http://www.proactiveinvestors.com/columns/jackhammer/28892/where-are-we-in-the-mining-investment-cycle-28892.html Interesting

the merger is nearing completion

Interesting: http://pumpedordumped.com/data/searchcompany.php?search=mafl If you wait long enough for the page to load it shows, according to Google Trends, that there has been more interest from the Czech Republic (which has been renamed Czechia) than the UK. Some one else eyeing up the minerals?

As below - the expected XMAS presents. I expect wizard's timetable may be overtaken by updates. The last hole (LS-MS-05) of this drilling program drilled through several faulted zones and was evaluated thoroughly before the core sample was sent to ALS Global in Seville, Spain for assaying. We expect the results to be returned to TH Crestgate within the next 2 to 3 weeks. Additionally, AGP Mineral Consultants of Canada have been retained to review and update the resource estimate. We expect a resource estimate on Lagoa Salgada to be completed before year-end.

? = why?

I would have preferred that the RNS had provided a reason about why he was stepping down from his role and position on the Board with immediate effect. Bearing in mind the halving of shareholder value over the last year I do not think that is being unreasonable. I do note that the website details about the board have been updated.

Please excuse my profanities but what is happening here: The Board of Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group") today announces that Antony Odell, Chief Executive Officer (CEO), will be stepping down from his role and position on the Board with immediate effect. If this was organised surely they would have updated their website - it still lists him as CEO: https://www.tissueregenix.com/about